Preventive Measures against the Development of Dementia in Old Age

Article information

Korean J Fam Med. 2022;43(3):157-167
Publication date (electronic) : 2022 May 20
doi : https://doi.org/10.4082/kjfm.21.0030
School and Community Health Education Unit, Department of Health Education, University of Ibadan, Ibadan, Nigeria
*Corresponding Author: Israel Oluwasegun Ayenigbara Tel: +234-8139177538, Fax: +234-809-810-3043, E-mail: histrealite2647@gmail.com
Received 2021 February 16; Revised 2022 April 22; Accepted 2022 May 7.

Abstract

Dementia is a neurological condition characterized by numerous types of central nervous system diseases, which gradually deteriorates an individual’s reasoning, rational thinking, and judgment abilities. As a serious public health concern that currently affects more than 50 million older adults, dementia is one of the most significant causes of incapacity, disability, and dependency among older adults. As new cases are expected to increase exponentially in the next three decades, dementia, which is not a normal feature of healthy aging despite the fact that it generally affects older adults disproportionately, requires enormous management and care efforts due to its associated socioeconomic, psychological, and physical burdens that involve the patient, their caregivers, guardians, family members, and society at large. Presently, there is no cure for dementia; however, this condition could be prevented. This narrative review aimed to provide a broad overview of studies detailing the alternative lifestyle modification-centered preventive measures against dementia. A comprehensive search of key databases to find articles related to this topic revealed that participating in regular physical activities, healthy eating and dieting, avoiding all forms of smoking, avoiding air pollutants, halting or reducing alcohol consumption, exercising the mind and being socially dynamic, getting enough rest and establishing good sleeping habits, infection prevention, stress prevention, avoidance of injuries, preventing the effects of social isolation and lockdowns, continuing education, and depression prevention are protective measures against the development of dementia.

INTRODUCTION

Dementia is a progressive neurological condition characterized by numerous types of central nervous system diseases that tends to worsen over time; it usually deteriorates an individual’s sound reasoning, rational thinking, and judgment abilities, thereby affecting the performance of normal day-to-day functioning and activities [1]. In some cases of dementia, an individual’s motivation, emotional control, and social conduct are affected, but consciousness and alertness in individuals are not usually hampered [2-4].

As a serious public health concern, dementia is one of the major causes of incapacity, disability, morbidity, and dependency among older adults [1,2]. Statistically, over 10 million patients are newly diagnosed with dementia every year, and a total of 50 million people worldwide are affected with this condition [2].

Furthermore, the World Health Organization (WHO) projected an exponential increase of 82 million cases of dementia in the next 10 years and 152 million by the year 2050 worldwide; this considerable upsurge in estimation is inferable to the increasing numbers of people with dementia living in underdeveloped and developing regions and countries around the world [2]. To this end, with the hope of abating the number of future cases of dementia, this review aimed to provide an overview of dementia, with a primary emphasis on scientifically proven lifestyle modification-centered preventive measures.

SOURCES OF INFORMATION AND METHODOLOGY

This narrative review aimed to provide information on dementia and to determine the appropriate measures that can prevent or reduce the severity of this condition based on the current literature. The literature search commenced between March 2020 and February 2021, and only significant studies published within the last 10 years were screened based on the topic of discourse from Medline (PubMed), Google Scholar, and specific global organizations, associations, and national health organization information archives, such as the WHO, National Institute on Aging, Alzheimer Disease International, and Alzheimer’s Research United Kingdom.

The search terms used were “dementia,” “prevalence of dementia,” and “prevention of dementia.” Furthermore, each of the returned results from the automated searches on the “prevention of dementia” was additionally searched to obtain a variety of cogent literature that extensively discussed this subheading. As this was a narrative research, all types of studies were eligible for inclusion in this review, including clinical trials, meta-analyses, randomized controlled trials, systematic and viable review documents, and website data.

After gathering all the searched results, thousands of articles were obtained; however, after reviewing the available data, the most significant works published on the aforementioned themes were downloaded, carefully reviewed, summarized, and reported in a narrative way taking into account the various issues involved. After careful screening of the abstracts of each article for content and face validity and in line with the set objectives of this study, 90 articles from Medline (PubMed), five articles from Google Scholar, seven articles from website data, and one book article, with a total of 103 articles, were included in this review.

PREVALENCE OF DEMENTIA

More than 9.9 million patients worldwide are diagnosed with dementia annually, and at least one new case is reported every 3.2 seconds [2]. Furthermore, 50 million individuals are living with dementia, with the vast majority or 60% living in underdeveloped and developing regions of the world, and the number of cases is expected to triple in the next three decades [2,5,6]. Current data show that dementia usually manifests in adults 60 years and older, with an average confirmed dementia cases of 5%–8% at a given point in time [2]. The exponential increase and increase in the number of forecasted dementia cases worldwide are attributed to the consistent increase in the number of individuals living with dementia in underdeveloped and developing regions and countries [2,6]. With 14.9 million confirmed cases, the Asian continent is the region with the vast majority of individuals living with dementia, followed by Western Europe (7.5 million) and North America (4.8 million); however, these figures are projected to dramatically increase in the coming years [5,6].

According to income status estimates, the number of adults living with dementia in low-income countries will increase by 264% [6]. It will increase by 227% in upper-middle-income countries, 223% in lower-middle-income countries, and 116% in higher-income countries in the next 30 years [6]. However, the burden of dementia is incalculable because it not only affects those with the condition alone, but also their caregivers, families, health care organizations, and the general public as a whole [2].

In addition to the significant burden imposed by dementia, the 9th most common burdensome condition affecting individuals >60 years of age, this condition is more common in women >65 years of age than in men [7]. In terms of economic estimates, US $818 billion were spent on the treatment and management of dementia in 2015 alone, accounting for 1.1% of the world’s gross domestic product [5]. Additionally, over US $1 trillion was expected to be spent on the treatment, care, and management of people living with dementia by the year 2020 [5]. In this regard, the yearly global expenditures and expenses associated with the treatment, care, and management of dementia cases surpass the market value of some major international organizations such as Apple and Google [5].

These general findings clearly pinpoint the severity and seriousness of dementia and its immense negative impact on the general health system and financial status of underdeveloped and developing countries, as well as developed countries across the globe.

EVIDENCE BASED PROGRAM REVIEW FOR PREVENTING DEMENTIA

Despite the fact that advanced age is the biggest risk factor for dementia, this condition is not part of the normal aging process. Presently, there is no known cure for dementia, but research evidence firmly shows some preventive measures that could help reduce the risk of having the disease [2,4]. Thus, the following, backed by scientific studies, are discussed extensively as probable public-centered proactive measures against the development of dementia and other forms of dementia (Figure 1).

Figure. 1.

Representation of the protective measures against the development of dementia. The sketch was self-developed.

ENGAGING IN REGULAR PHYSICAL ACTIVITY

Exercise has emerged as a key intervention for positively influencing comprehension and cognition as well as reducing the risk of age-related cognitive decline and dementia [8]. In addition,, performing regular physical exercise strengthens antioxidative capacity, reduces oxidative stress, and exerts anti-inflammatory effects, which further improve the endothelial function and can increase brain capillarization [9]. In addition, physical activity can counteract dyslipidemia and decrease the ceramide levels, while also improving the amyloid-β (Aβ) clearance by upregulating the Aβ transporters and increasing the basal testosterone levels [9].

Significantly, a minimum of 150 minutes of temperate aerobic physical activity every week in combination with additional resistance training is imperative to keep the brain healthy in individuals with subjective cognitive decline and mild cognitive impairment [10]. Likewise, a concentrated exercise program (specifically a 4-week program), regardless of whether this is a strength or aerobic training program, offers substantial advantages to older patients with dementia, and the serum brain-derived neurotrophic factor will be additionally enhanced by performing aerobic training [11]. Furthermore, a combination of aerobic and strength training activities is more effective than aerobic activity alone in slowing the cognitive and motor decline in adults with dementia [12,13]. Specifically, physical activity improves cognition and comprehension, particularly executive functioning and memory, and independent functioning in patients with dementia [13,14].

Findings from a large and long-term randomized controlled trial study on the effects of multidomain interventions such as diet, exercise, cognitive training, and vascular risk monitoring on the cognitive decline in high-risk older people revealed that the simultaneous performance of physical activity, nutritional counseling, vascular risk monitoring and management, and cognitive training and social activity could improve or maintain cognitive function regardless of the individuals’ characteristics [15-17]. Importantly, findings from a large study on the effect of a 2-year physical activity intervention compared with health education on cognitive outcomes in sedentary older adults revealed that a 24-month minimal intensity physical activity program did not improve the cognitive or composite measures of the participants, compared with a health education program [18]; however, these findings should not disregard the overall beneficial effects of physical activities on well-being and cognitive function.

CONSUMING A REGULAR HEALTHY DIET

In the prevention and treatment of mental disorders, the role of an appropriately adjusted eating regimen such as the consumption of fresh fruits, can significantly prevent depressive disorders as they contain high amounts of nutrients that the body needs [19,20]. For instance, increased consumption of natural fruits and vegetables, specifically berries, citrus, and green leafy vegetables, may promote higher levels of optimism and self-efficacy; reduce the level of psychological distress, ambiguity, and malignancy fatalism; and protect against depressive symptoms [20]. Moreover, the consumption of high-quality food was associated with a decreased risk of experiencing a global cognitive decline compared with consumption of low-quality food [21]. In addition, the consumption of long-term dewaxed brown rice reduces and prevents cognitive deterioration, particularly in older individuals with decreased cognitive capabilities [22].

Importantly, there is a beneficial relationship between the Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for neurodegenerative delay diet and cognitive functioning, while increased consumption of saturated fatty acids could have negative impacts on age-related cognitive decline and are thus not recommended [23-25]. Furthermore, consumption of monounsaturated fatty acids and polyunsaturated fatty acids (PUFA; specifically, n-3 PUFA) decreases the risk of cognitive deterioration, decline, and impairment, and dementia [25]. On the contrary, poorer intellectual function is related to a reduced consumption of milk or dairy products, whereas the consumption of whole-fat dairy products may be associated with a higher risk of cognitive decline and deterioration among older adults [25]. Additionally, adherence to a healthy eating regimen and diet decreases oxidative stress, inflammation, and Aβ levels, which could subsequently lower the risk of dementia-like symptoms [26].

SMOKING CESSATION

Cigarette smoking is a major determinant of the development of dementia as it is associated with the extracellular deposition of amyloid plaques and peptides in the brain [27]. Findings on the effects of cigarette smoke components, such as nicotine, polycyclic aromatic hydrocarbons (PAHs), Cd(II), Cr(III), Pb(II), and Pb(IV) ions, on Aβ peptide aggregation revealed that all PAHs and metal ions modulated the Aβ aggregation process [27]. Furthermore, there is a significant relationship between active cigarette and tobacco smoking in older individuals with normal cognitive function and increased cerebral oxidative stress, while the association is smaller in those with dementia [27].

A study on active cigarette smoking in older individuals with normal cognitive function and possible dementia risk showed that smoking is related to increased oxidative stress in the central nervous system [28], while findings from a systematic review on the association between smoking and an increased risk of developing Alzheimer’s disease (AD) showed a relationship between smoking, nicotine exposure, and dementia-related neuropathology [29]. In addition, exposure to smoke is associated with an increased risk of negative preclinical and cognitive outcomes in younger and older adults [30], while recent evidence further implicates that medicinal nicotine is conceivably harmful to the neurodevelopmental condition in children and catalyzing processes underlying the neuropathology of AD; hence, smoking issues should be addressed by all public health workers [31,32].

AIR POLLUTION PREVENTION

Emerging evidence showed that increased exposure to airborne pollutants, such as particulate matter ≤2.5 μ, nitrogen dioxide or nitrous oxides, and carbon monoxide, was associated with an increased risk of dementia, while exposure to these air pollutants, even at low, reduced, and residential levels, was positively associated with a higher incidence of dementia [33-35]. Furthermore, findings from a longitudinal study on long-term exposure to air pollution and hospitalization due to dementia revealed a positive association between exposure to nitrogen oxides and ozone and hospitalization due to dementia [36]; meanwhile, results from similar studies on the association between fine particulate matter and ground-level ozone concentrations and amyloid positron emission tomography positivity in older adults with cognitive impairment revealed a positive association between higher fine particulate matter concentrations and brain amyloid plaques [37,38].

REDUCING/ELIMINATING ALCOHOL CONSUMPTION

Importantly, the diagnosis of an alcohol use disorder is strongly associated with a higher risk of dementia; however, the dose-response relationship between alcohol consumption and cognitive impairment remains unclear [39]. Findings from a systematic scoping review on alcohol use and dementia revealed that light to moderate alcohol use in middle to late adulthood was associated with a reduced risk of cognitive impairment and dementia, but heavy alcohol use was associated with changes in brain structures, cognitive debilitation and impairments, and an increased risk of all types of dementia [40,41]. In addition, a previous study showed that older adult drinkers are at high risk for cognitive deterioration, decline, and dementia [42], while the risk of dementia was increased in people who abstained from consuming alcohol in midlife or consumed >14 units per week [43]. The harmful amount of alcohol intake in many countries is >14 units per week; consequently, there is a proactive need for a downward revision of such guidelines to promote cognitive health in older ages [43]. In another study, total abstinence and intake of >14.0 drinks per week (compared with intake of <1.0 drink per week) was associated with reduced cognitive scores among study participants aged 72 years and older [44]. Findings from a study on the association of low to moderate alcohol drinking on cognitive functions from middle to old age among American adults revealed that <8 drinks per week for women and <15 drinks per week for men were positively associated with a consistently high cognitive function trajectory and a lower rate of cognitive decline, while low to moderate drinking was associated with decreased annual rates of total cognitive function decline, word recall, and vocabulary [45].

EXERCISING THE MIND AND SOCIAL ACTIVENESS

Engaging in stimulating activities, either intellectually, mentally, or socially, could protect individuals from developing dementia, indicating that social association, interaction, and intellectual stimulation could be pertinent in preserving mental alertness and functioning in older people [46,47]. Increasing evidence show that participation in cognitively stimulating recreational activities may help reduce the risk of cognitive impairment and dementia in the future [48-50]. Similarly, engaging in stimulating and exciting recreational activities is a protective measure against cognitive deterioration and decline and dementia in older people [51]. For instance, a study indicated that game-based interventions, specifically playing of video games, could improve cognitive abilities and functioning, such as executive functions in dementia patients and older adults. Additionally, the positive outcomes and impacts of moderate video gaming on gamers’ physical health have also been observed, for example, improvement in gait and balance [52].

Furthermore, playing video games could mitigate behavioral or mood disorders, and increase collaborations and interactions with friends, relatives, caregivers, guardians, and other patients; moreover, the beneficial effects of playing video games on social isolation, physical and cognitive decline, or deterioration are also impressive [53,54]. However, caution must be taken when playing video games and engaging in active gaming to prevent video game addiction, which results in health consequences that outwit the beneficial effects of moderate video gaming [55].

GOOD SLEEP HABITS

Epidemiologically, the onset of age-related neurodegenerative diseases such as AD and Parkinson’s disease is related to articulated sleep and rest disruption or disturbance, while emergent mechanistic studies propose that sleep interruption and disruption might be causally associated to the development of neurodegenerative diseases, suggesting that adequate rest and sleep may be a viable therapeutic or remedial target in preventing these events [56]. In addition, sleep disruption is a major component of early dementia because insufficient sleep facilitates the accumulation of Aβ [57,58]. Furthermore, the core manifestations of persistently disrupted sleep and circadian rhythms can weaken or impair memory and hippocampus-dependent learning; sleep disturbance is also a risk factor for early dementia [59]. Importantly, findings of previous studies on the impact of poor sleep quality on subjective cognitive decline or related functional difficulties have indicated that poor sleep quality may lead to cognitive, functional, or ability decline [60].

Habitual short (≤6 hours/night) or long (≥8 hours/night) sleep duration (against 7 hours/night) may increase the future risk for developing cognitive impairments, including dementia, independent of the vascular risk factors by 36% and 35%, respectively, in older women; meanwhile, various forms of sleep conditions or parameters such as insomnia, fragmentation, daytime dysfunction, prolonged latency, rapid eye movement sleep behavior disorder, and excessive time in bed were linked to a higher risk of all-cause cognitive disorders. Consequently, adequate sleep management is considered a viable option for dementia prevention [61-64].

Moreover, sleep apnea, which affects 17% of 50–70-year-old men and 9% of 50–70-year-old women, increases the risk of hypertension, stroke, myocardial infarction, and atrial fibrillation, and is closely linked to vascular dementia [65]. In addition, findings from studies on self-reported sleep apnea and dementia risk indicated that sleep apnea may increase the risk of dementia by 66% in the absence of the apolipoprotein E (APOE) ε4 allele, which may be helpful in the prevention of dementia or AD in older men with sleep apnea [66].

Importantly, treating various sleep problems is beneficial to improving cognitive health because treating sleep disorders in older patients prevents and delays the onset of dementia, mitigates the progression of symptoms in people who already manifest dementia symptoms, and even reverses neurodegeneration in specific brain areas [67].

CONTROLLING HEALTH RISKS

Before the midlife stage, individuals should provide adequate attention to improving their overall health. For instance, hypertension presents a higher risk factor for cognitive decline and various forms of dementia [68]. In addition, elevated concentrations of low-density lipoprotein cholesterol (>121 mg/dL), which is a risk factor for other numerous noncommunicable diseases, is a potential risk factor for AD, and this association is stronger among individuals aged 60–70 years [69,70]. Furthermore, diabetes is also a risk factor for dementia and other neurological conditions [71]. In addition, presbycusis (hearing loss) is one of the causes of various human cognitive disorders and increases the risk of dementia in older people [72].

PREVENTION OF INFECTION

A positive correlation exists between Helicobacter pylori infection and dementia [73]. Strong evidence also revealed that herpes simplex virus type 1 is a significant risk factor for AD through the intermittent reactivation of APOE gene by immunosuppression, peripheral infection, and inflammation [74]. In addition, the number of cases of human immunodeficiency virus (HIV)-related neurocognitive disorder and HIV-related myelopathy has increased in patients with advanced immunosuppression due to HIV infection [75].

Findings from a meta-analytic study revealed that Toxoplasma gondii infection could be considered as a risk factor for AD and could exacerbate its symptoms [76], while infections caused by Botrytis cinerea, Cryptococcus curvatus, Alternaria, Botrytis, Candida, Cladosporium, and Malassezia are major risk factors for AD [77].

Furthermore, cytomegalovirus and herpes simplex virus type 1 are risk factors for the development of AD through their probable effects on the immune system [78]. Likewise, neurosyphilis, a bacterial infection caused by Treponema pallidum, can cause significant variations in neuropsychiatric signs and symptoms in individuals [79]; meanwhile, parasitic infestations mostly found in places with poor sanitation, which can cause neurocysticercosis in the brain, is also a risk factor for dementia [80].

STRESS PREVENTION

Several studies have highlighted the association between stress and dementia. The risk of dementia is higher in persons with stress disorders than in those without, while a higher rate of dementia was recorded in men with stress disorders than in women who had higher rates of posttraumatic stress disorder [81]. In addition, midlife work-related stress increases the risk of mild cognitive impairment, dementia, and AD in later life [82]. Furthermore, post-traumatic stress disorder and depressive disorders are associated with an increased risk of dementia [83]. To this end, the implementation of appropriate stress management measures will help mitigate these effects [84].

AVOIDANCE OF INJURIES

There is a long history linking traumatic brain injury (TBI) with the development of dementia. TBI occurs when a force transmitted to the head causes neuropathologic damage and impairment of brain function, which increases the risk of developing AD, Parkinson’s disease, and chronic traumatic encephalopathy, and is also a risk factor for sporadic amyotrophic lateral sclerosis [85]. In summary, through several potential mechanisms, a single moderate-to-severe TBI increases the risk of AD, repetitive and mild TBI increases the risk of chronic traumatic encephalopathy, and TBI may be a risk factor for other neurodegenerative disorders that are associated with dementia [86].

PREVENTING THE IMPACTS OF SOCIAL ISOLATION AND LOCKDOWN

As social isolation or loneliness is associated with a 40% increased risk of dementia regardless of gender, race, ethnicity, education, and genetic risk [87], people, especially older adults should not be neglected or left alone. In addition, perceived loneliness is a significant risk factor for all-cause dementia, especially for AD; hence, paying attention to the subjective reports of loneliness among older adults could help prevent this condition, while the lack of social interaction with others is also associated with risks of dementia [88,89]. To this end, the general prevention of loneliness and isolation is essential in achieving overall cognitive health [90].

PREVENTION OF DEPRESSION

The odds of developing all-cause dementia is higher in people with a history of depression and anxiety than in those with no history of these conditions, while a high level of depressive symptoms is associated with a 50% increased risk of dementia [91,92]. In addition, depressive symptoms may be both a risk factor for and a harbinger of dementia, as an increase in the number of depressive symptoms is associated with a higher risk of dementia than a decrease in the number of depressive symptoms [93,94]. In addition, findings from previous studies on the association of depressive symptoms with a decline in cognitive function-Rugao longevity and aging revealed that people with deteriorating levels of depression tended to experience a rapid decline in cognitive and intellectual abilities than those with steady depression [95].

Furthermore, major depressive disorder is a significant risk factor for the onset and aggravation of dementia, and patients with this type of condition exhibiting different subtypes of mild cognitive impairment typically show beta-amyloid deposition on brain imaging; a high prevalence of minimal cognitive impairment was also evident among older depressed patients, and depressed patients with minimal cognitive impairment showed heterogeneously elevated 18F-florbetapir retention compared with depressed patients without minimal cognitive impairment [96,97]. These findings support the hypothesis that a higher amyloid burden is associated with poorer memory performance and higher susceptibility to the development of AD in the future.

CONTINUING EDUCATION

A previous study showed that cognitively stimulating activities performed during middle adulthood might have a protective effect on the brain by boosting the cognitive reserve; results of available studies further demonstrate that cognitive reserve is increased through continuing education, which lowers the incidence of dementia [98]. Furthermore, findings from a previous study on education and adolescent cognitive ability as predictors of dementia revealed that continuing education and maintaining a good cognitive ability can decrease the risk of dementia independently of one another, and an increase in educational attainment may offset the dementia risk due to improved cognitive abilities [99].

DISCUSSION

Over the years, scientists have been able to proffer some alternative preventive measures for dementia; nevertheless, by 2030 and 2050, 82 million and 152 million people worldwide, respectively, are predicted to be living with dementia due to the rising number of cases in underdeveloped and developing countries. Again, these statistics affirm the envisaged future seriousness and additional medical burdens likely to ensue from the condition.

Presently, as the coronavirus disease 19 pandemic continues, social isolation and lockdowns are some of the measures implemented to abate the spread of the virus [100]; however, these measures might increase or aggravate the number of dementia cases worldwide. While most cases of dementia are reported in Asia, Western Europe, and North American countries, future cases are expected to soar in the coming years in other regions and continents of the world; thus, concerted efforts of all health practitioners are needed to mitigate this occurrence.

As a neurological and chronic condition, dementia exerts both financial and mental health burdens on the patients and their loved ones. The primary healthcare system and nursing homes are also exhausted and impacted in dealing with cases of dementia; furthermore, the healthcare budgetary allocations of some specific countries for the treatment and management of dementia cases are also increasing on a yearly basis.

Although dementia mostly affects older populations, this condition should not be associated or mistaken as a normal part of aging. Dementia is commonly caused by a damage in the brain or its components. There are other numerous factors that can cause dementia; some are reversible once the conditions are treated, while others cannot be reversed but can be prevented.

Importantly, AD is well documented as the most common type of dementia. The stages of AD vary and can be described hierarchically, that is, low to moderate to severe, and includes: no cognitive impairment, very mild cognitive decline, mild cognitive decline, moderate cognitive decline, moderately severe cognitive decline, severe cognitive decline, and very severe cognitive decline. In most cases, non-pharmacological interventions are mostly beneficial in reversing, delaying, and improving the health conditions of patients in most stages of AD, except in patients with extremely severe cognitive decline as they tend to lose their ability to communicate or respond to their environment [101,102].

Since the attention and priorities of health practitioners are to repress the occurrence of dementia globally, joint efforts should be geared toward the prevention of this condition as there are no effective pharmacological interventions available for the permanent treatment of dementia. Notably, preventive interventions for dementia are less expensive, adoptable, and effective, and only involve behavioral and lifestyle changes. The changeable risk factors for dementia are usually the main focus in the probable and workable preventive efforts of health educators and other health practitioners in order to manage dementia; other cognitive problems, summaries, and key points to this effect are provided in Table 1.

Summaries of preventive options to mitigate the onset and progression of dementia

CONCLUSION

There is a growing emphasis on strategies to prevent dementia globally [103]. This review concludes that participating in regular physical activities, healthy eating and dieting, avoiding all forms of smoking, avoiding air pollutants, halting or reducing alcohol consumption, exercising the mind and being socially dynamic, getting enough rest and establishing good sleep habits, infection prevention, stress prevention, avoidance of injuries, prevention of the effects of social isolation and lockdowns, continuing education, and depression prevention are viable protective measures against the development of dementia.

Notes

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

Acknowledgements

Great thanks and appreciations to my mentor Prof. R. Marks, Teachers College, Columbia University, New York, the United States who helped to proofread the initial full manuscript for appropriateness, and offered valuable suggestions. Thanks and appreciations go to all the scientists whose studies have been discussed in this article; also, great appreciation is given to the anonymous reviewers of this journal for their valuable suggestions.

References

1. World Health Organization. Dementia [Internet]. Geneva: World Health Organization; 2015. [cited 2021 Feb 9]. Available from: https://web.archive.org/web/20150318030901/http://www.who.int/media-centre/factsheets/fs362/en.
2. World Health Organization. Dementia [Internet]. Geneva: World Health Organization; 2019. [cited 2021 Feb 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
3. National Institute on Aging. What is dementia? symptoms, types, and diagnosis [Internet]. Bethesda (MD): National Institute on Aging; 2019. [cited 2021 Feb 9]. Available from: https://www.nia.nih.gov/health/what-dementia-symptoms-types-and-diagnosis.
4. Alzheimer’s Society. What is dementia? [Internet]. London: Alzheimer’s Society; 2019. [cited 2021 Feb 9]. Available from: https://www.alzheimers.org.uk/about-dementia/types-dementia/what-dementia.
5. Alzheimer’s Disease International. Dementia statistics [Internet]. London: Alzheimer Disease International; 2020. [cited 2021 Feb 9]. Available from: https://www.alz.co.uk/research/statistics.
6. Alzheimer’s Research UK. Global prevalence [Internet]. Cambridge: Alzheimer’s Research UK; 2018. [cited 2021 Feb 9]. Available from: https://www.dementiastatistics.org/statistics/global-prevalence/.
7. Sadock BJ, Sadock VA. Delirium, dementia, and amnestic and other cognitive disorders and mental disorders due to a general medical condition. In : Sadock BJ, Sadock VA, eds. Kaplan & Sadock’s concise textbook of clinical psychiatry 3rd edth ed. Philadelphia (PA): Wolters Kluwer/Lippincott Williams & Wilkins; 2008. p. 46–79.
8. Alty J, Farrow M, Lawler K. Exercise and dementia prevention. Pract Neurol 2020;20:234–40.
9. Bertram S, Brixius K, Brinkmann C. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients. Endocrine 2016;53:350–63.
10. Lautenschlager NT, Cox KL, Ellis KA. Physical activity for cognitive health: what advice can we give to older adults with subjective cognitive decline and mild cognitive impairment? Dialogues Clin Neurosci 2019;21:61–8.
11. Liu IT, Lee WJ, Lin SY, Chang ST, Kao CL, Cheng YY. Therapeutic effects of exercise training on elderly patients with dementia: a randomized controlled trial. Arch Phys Med Rehabil 2020;101:762–9.
12. Bossers WJ, van der Woude LH, Boersma F, Hortobagyi T, Scherder EJ, van Heuvelen MJ. A 9-week aerobic and strength training program improves cognitive and motor function in patients with dementia: a randomized, controlled trial. Am J Geriatr Psychiatry 2015;23:1106–16.
13. Nuzum H, Stickel A, Corona M, Zeller M, Melrose RJ, Wilkins SS. Potential benefits of physical activity in MCI and dementia. Behav Neurol 2020;2020:7807856.
14. Ayenigbara IO. The contributions of physical activity and fitness for the optimal health and wellness of the elderly people. J Gerontol Geriatr 2020;68:40–6.
15. Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomized controlled trial. Lancet 2015;385:2255–63.
16. Rosenberg A, Ngandu T, Rusanen M, Antikainen R, Backman L, Havulinna S, et al. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimers Dement 2018;14:263–70.
17. Kulmala J, Ngandu T, Havulinna S, Levalahti E, Lehtisalo J, Solomon A, et al. The effect of multidomain lifestyle intervention on daily functioning in older people. J Am Geriatr Soc 2019;67:1138–44.
18. Sink KM, Espeland MA, Castro CM, Church T, Cohen R, Dodson JA, et al. Effect of a 24-month physical activity intervention vs health education on cognitive outcomes in sedentary older adults: the LIFE randomized trial. JAMA 2015;314:781–90.
19. Ayenigbara I. The role of healthy nutrition and diet in the prevention of non-communicable diseases among the aged. Geriatr Care 2019;5:7961.
20. Glabska D, Guzek D, Groele B, Gutkowska K. Fruit and vegetable intake and mental health in adults: a systematic review. Nutrients 2020;12:115.
21. Chou YC, Lee MS, Chiou JM, Chen TF, Chen YC, Chen JH. Association of diet quality and vegetable variety with the risk of cognitive decline in Chinese older adults. Nutrients 2019;11:1666.
22. Uenobe M, Saika T, Waku N, Ohno M, Inagawa H. Effect of continuous dewaxed brown rice ingestion on the cognitive function of elderly individuals. J Nutr Sci Vitaminol (Tokyo) 2019;65(Supplement):S122–4.
23. Munoz-Garcia MI, Toledo E, Razquin C, Dominguez LJ, Maragarone D, Martinez-Gonzalez J, et al. “A priori” dietary patterns and cognitive function in the SUN project. Neuroepidemiology 2020;54:45–57.
24. Hosking DE, Eramudugolla R, Cherbuin N, Anstey KJ. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement 2019;15:581–9.
25. Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, et al. Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Rev Neurother 2011;11:677–708.
26. Samadi M, Moradi S, Moradinazar M, Mostafai R, Pasdar Y. Dietary pattern in relation to the risk of Alzheimer’s disease: a systematic review. Neurol Sci 2019;40:2031–43.
27. Wallin C, Sholts SB, Osterlund N, Luo J, Jarvet J, Roos PM, et al. Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation. Sci Rep 2017;7:14423.
28. Calderon-Garciduenas L. Smoking and cerebral oxidative stress and air pollution: a dreadful equation with particulate matter involved and one more powerful reason not to smoke anything! J Alzheimers Dis 2016;54:109–12.
29. Durazzo TC, Korecka M, Trojanowski JQ, Weiner MW, O’ Hara R, Ashford JW, et al. Active cigarette smoking in cognitively-normal elders and probable Alzheimer’s disease is associated with elevated cerebrospinal fluid oxidative stress biomarkers. J Alzheimers Dis 2016;54:99–107.
30. Durazzo TC, Mattsson N, Weiner MW, ; Alzheimer’s Disease Neuroimaging Initiative. Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement 2014;10(3 Suppl):S122–45.
31. Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 2007;17:259–73.
32. Tavee J. Smoking cessation for the neurologic patient. Neurol Clin Pract 2012;2:112–121.
33. Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and dementia: a systematic review. J Alzheimers Dis 2019;70(s1):S145–63.
34. Chen H, Kwong JC, Copes R, Hystad P, van Donkelaar A, Tu K, et al. Exposure to ambient air pollution and the incidence of dementia: a population-based cohort study. Environ Int 2017;108:271–7.
35. Carey IM, Anderson HR, Atkinson RW, Beevers SD, Cook DG, Strachan DP, et al. Are noise and air pollution related to the incidence of dementia?: a cohort study in London, England. BMJ Open 2018;8e022404.
36. Cerza F, Renzi M, Gariazzo C, Davoli M, Michelozzi P, Forastiere F, et al. Long-term exposure to air pollution and hospitalization for dementia in the Rome longitudinal study. Environ Health 2019;18:72.
37. Iaccarino L, La Joie R, Lesman-Segev OH, Lee E, Hanna L, Allen IE, et al. Association between ambient air pollution and amyloid positron emission tomography positivity in older adults with cognitive impairment. JAMA Neurol 2021;78:197–207.
38. Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, et al. Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting. JAMA Neurol 2018;75:970–9.
39. Rao R, Topiwala A. Alcohol use disorders and the brain. Addiction 2020;115:1580–9.
40. Rehm J, Hasan OS, Black SE, Shield KD, Schwarzinger M. Alcohol use and dementia: a systematic scoping review. Alzheimers Res Ther 2019;11:1.
41. Hoffman JL, Faccidomo S, Kim M, Taylor SM, Agoglia AE, May AM, et al. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer’s disease. Int Rev Neurobiol 2019;148:169–230.
42. Sullivan EV, Pfefferbaum A. Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: a review. Neuropsychology 2019;33:760–80.
43. Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ 2018;362:k2927.
44. Koch M, Fitzpatrick AL, Rapp SR, Nahin RL, Williamson JD, Lopez OL, et al. Alcohol consumption and risk of dementia and cognitive decline among older adults with or without mild cognitive impairment. JAMA Netw Open 2019;2e1910319.
45. Zhang R, Shen L, Miles T, Shen Y, Cordero J, Qi Y, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults. JAMA Netw Open 2020;3e207922.
46. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 2002;155:1081–7.
47. Marseglia A, Wang HX, Rizzuto D, Fratiglioni L, Xu W. Participating in mental, social, and physical leisure activities and having a rich social network reduce the incidence of diabetes-related dementia in a cohort of Swedish older adults. Diabetes Care 2019;42:232–9.
48. Yates LA, Ziser S, Spector A, Orrell M. Cognitive leisure activities and future risk of cognitive impairment and dementia: systematic review and meta-analysis. Int Psychogeriatr 2016;28:1791–806.
49. Stern C, Munn Z. Cognitive leisure activities and their role in preventing dementia: a systematic review. Int J Evid Based Healthc 2010;8:2–17.
50. Kim MJ, Tsutsumimoto K, Doi T, Nakakubo S, Kurita S, Makizako H, et al. Relationships between cognitive leisure activities and cognitive function in older adults with depressive symptoms: a cross-sectional study. BMJ Open 2020;10e032679.
51. Ching-Teng Y. Effect of board game activities on cognitive function improvement among older adults in adult day care centers. Soc Work Health Care 2019;58:825–38.
52. Narme P. Benefits of game-based leisure activities in normal aging and dementia. Geriatr Psychol Neuropsychiatr Vieil 2016;14:420–8.
53. Iizuka A, Suzuki H, Ogawa S, Kobayashi-Cuya KE, Kobayashi M, Takebayashi T, et al. Can cognitive leisure activity prevent cognitive decline in older adults?: a systematic review of intervention studies. Geriatr Gerontol Int 2019;19:469–82.
54. Bah TM, Goodman J, Iliff JJ. Sleep as a therapeutic target in the aging brain. Neurotherapeutics 2019;16:554–68.
55. Ayenigbara IO. Gaming disorder and effects of gaming on health: an overview. J Addict Med Ther Sci 2017;4:1–3.
56. Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer’s disease? Trends Neurosci 2016;39:552–66.
57. Kent BA, Mistlberger RE. Sleep and hippocampal neurogenesis: implications for Alzheimer’s disease. Front Neuroendocrinol 2017;45:35–52.
58. Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol 2019;18:296–306.
59. Minakawa EN, Wada K, Nagai Y. Sleep disturbance as a potential modifiable risk factor for Alzheimer’s disease. Int J Mol Sci 2019;20:803.
60. Lee JE, Ju YJ, Park EC, Lee SY. Effect of poor sleep quality on subjective cognitive decline (SCD) or SCD-related functional difficulties: results from 220,000 nationwide general populations without dementia. J Affect Disord 2020;260:32–7.
61. Chen JC, Espeland MA, Brunner RL, Lovato LC, Wallace RB, Leng X, et al. Sleep duration, cognitive decline, and dementia risk in older women. Alzheimers Dement 2016;12:21–33.
62. Xu W, Tan CC, Zou JJ, Cao XP, Tan L. Sleep problems and risk of allcause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2020;91:236–44.
63. Carvalho DZ, St Louis EK, Knopman DS, Boeve BF, Lowe VJ, Roberts RO, et al. Association of excessive daytime sleepiness with longitudinal β-amyloid accumulation in elderly persons without dementia. JAMA Neurol 2018;75:672–80.
64. Spira AP, An Y, Wu MN, Owusu JT, Simonsick EM, Bilgel M, et al. Excessive daytime sleepiness and napping in cognitively normal adults: associations with subsequent amyloid deposition measured by PiB PET. Sleep 2018;41:zsy152.
65. Culebras A, Anwar S. Sleep apnea is a risk factor for stroke and vascular dementia. Curr Neurol Neurosci Rep 2018;18:53.
66. Ding X, Kryscio RJ, Turner J, Jicha GA, Cooper G, Caban-Holt A, et al. Self-reported sleep apnea and dementia risk: findings from the prevention of Alzheimer’s disease with vitamin E and selenium trial. J Am Geriatr Soc 2016;64:2472–8.
67. Kitamura T, Miyazaki S, Sulaiman HB, Akaike R, Ito Y, Suzuki H. Insomnia and obstructive sleep apnea as potential triggers of dementia: is personalized prediction and prevention of the pathological cascade applicable? EPMA J 2020;11:355–65.
68. Sierra C. Hypertension and the risk of dementia. Front Cardiovasc Med 2020;7:5.
69. Zhou Z, Liang Y, Zhang X, Xu J, Lin J, Zhang R, et al. Low-density lipoprotein cholesterol and Alzheimer’s disease: a systematic review and meta-analysis. Front Aging Neurosci 2020;12:5.
70. Ayenigbara IO. The accumulation of visceral fat and preventive measures among the elderly. Cardiovasc Innov Appl 2020;4:279–85.
71. Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer’s disease and other metabolic disorders. Neural Regen Res 2020;15:1460–70.
72. Kunelskaya NL, Levina YV, Garov EV, Dzuina AV, Ogorodnikov DS, Nosulya EV, et al. Presbyacusis. Vestn Otorinolaringol 2019;84:67–71.
73. Tsolaki F, Kountouras J, Topouzis F, Tsolaki M. Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected? BMC Ophthalmol 2015;15:24.
74. Itzhaki RF. Corroboration of a major role for herpes simplex virus type 1 in Alzheimer’s disease. Front Aging Neurosci 2018;10:324.
75. Ayele BA, Amogne W, Gemechu L. HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review. BMC Infect Dis 2020;20:574.
76. Nayeri Chegeni T, Sarvi S, Moosazadeh M, Sharif M, Aghayan SA, Amouei A, et al. Is Toxoplasma gondii a potential risk factor for Alzheimer’s disease?: a systematic review and meta-analysis. Microb Pathog 2019;137:103751.
77. Alonso R, Pisa D, Aguado B, Carrasco L. Identification of fungal species in brain tissue from Alzheimer’s disease by next-generation sequencing. J Alzheimers Dis 2017;58:55–67.
78. Lovheim H, Olsson J, Weidung B, Johansson A, Eriksson S, Hallmans G, et al. Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer’s disease development. J Alzheimers Dis 2018;61:939–45.
79. Cassiani-Miranda CA, Chen X. Neurocognitive disorder due to neurosyphilis: a case report. Rev Colomb Psiquiatr (Engl Ed) 2020;49:202–7.
80. Wiwanitkit V. Dementia and neurocysticercosis. Acta Neurol Taiwan 2014;23:1–3.
81. Gradus JL, Horvath-Puho E, Lash TL, Ehrenstein V, Tamang S, Adler NE, et al. Stress disorders and dementia in the Danish population. Am J Epidemiol 2019;188:493–9.
82. Sindi S, Hagman G, Hakansson K, Kulmala J, Nilsen C, Kareholt I, et al. Midlife work-related stress increases dementia risk in later life: the CAIDE 30-year study. J Gerontol B Psychol Sci Soc Sci 2017;72:1044–53.
83. Rafferty LA, Cawkill PE, Stevelink SA, Greenberg K, Greenberg N. Dementia, post-traumatic stress disorder and major depressive disorder: a review of the mental health risk factors for dementia in the military veteran population. Psychol Med 2018;48:1400–9.
84. American Psychological Association. Coping with stress at work [Internet]. Washington (DC): American Psychological Association; 2020. [cited 2021 Feb 9]. Available from: https://www.apa.org/topics/workstress.
85. VanItallie TB. Traumatic brain injury (TBI) in collision sports: possible mechanisms of transformation into chronic traumatic encephalopathy (CTE). Metabolism 2019;100S:153943.
86. Mendez MF. What is the relationship of traumatic brain injury to dementia? J Alzheimers Dis 2017;57:667–81.
87. Sutin AR, Stephan Y, Luchetti M, Terracciano A. Loneliness and risk of dementia. J Gerontol B Psychol Sci Soc Sci 2020;75:1414–22.
88. Sundstrom A, Adolfsson AN, Nordin M, Adolfsson R. Loneliness increases the risk of all-cause dementia and Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci 2020;75:919–26.
89. Kuiper JS, Zuidersma M, Oude Voshaar RC, Zuidema SU, van den Heuvel ER, Stolk RP, et al. Social relationships and risk of dementia: a systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev 2015;22:39–57.
90. Ayenigbara IO, Moronkola OA. COVID-19: measures to protect older adults from SARS-CoV-2 infection. Geriatr Care 2020;6:9045.
91. Kuring JK, Mathias JL, Ward L. Risk of dementia in persons who have previously experienced clinically-significant depression, anxiety, or PTSD: a systematic review and meta-analysis. J Affect Disord 2020;274:247–61.
92. Lenoir H, Dufouil C, Auriacombe S, Lacombe JM, Dartigues JF, Ritchie K, et al. Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis 2011;26:27–38.
93. Gutzmann H, Qazi A. Depression associated with dementia. Z Gerontol Geriatr 2015;48:305–11.
94. Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H, et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry 2016;3:628–35.
95. Hou Z, Wang X, Wang Y, Wang J, Zhong J. Association of depressive symptoms with decline of cognitive function-Rugao longevity and ageing study. Neurol Sci 2020;41:1873–9.
96. Wu KY, Liu CY, Chen CS, Chen CH, Hsiao IT, Hsieh CJ, et al. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study. Eur J Nucl Med Mol Imaging 2016;43:1067–76.
97. Wu KY, Hsiao IT, Chen CS, Chen CH, Hsieh CJ, Wai YY, et al. Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging 2014;41:714–22.
98. Matyas N, Keser Aschenberger F, Wagner G, Teufer B, Auer S, Gisinger C, et al. Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review and overview of systematic reviews. BMJ Open 2019;9e027719.
99. Foverskov E, Glymour MM, Mortensen EL, Osler M, Okholm GT, Lund R. Education and adolescent cognitive ability as predictors of dementia in a cohort of Danish men. PLoS One 2020;15e0235781.
100. Ayenigbara IO, Adeleke OR, Ayenigbara GO, Adegboro JS, Olofintuyi OO. COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures. Germs 2020;10:218–28.
101. Regier NG, Hodgson NA, Gitlin LN. Characteristics of activities for persons with dementia at the mild, moderate, and severe stages. Gerontologist 2017;57:987–97.
102. Sarkamo T, Tervaniemi M, Laitinen S, Numminen A, Kurki M, Johnson JK, Rantanen P. Cognitive, emotional, and social benefits of regular musical activities in early dementia: randomized controlled study. Gerontologist 2014;54:634–50.
103. Tipton PW, Graff-Radford NR. Prevention of late-life dementia: what works and what does not. Pol Arch Intern Med 2018;128:310–6.

Article information Continued

Figure. 1.

Representation of the protective measures against the development of dementia. The sketch was self-developed.

Table 1.

Summaries of preventive options to mitigate the onset and progression of dementia

No. Preventive options Key findings
1 Engaging in regular physical activity Exercise is a key intervention for improving comprehension and cognition. A minimum of 150 minutes of temperate aerobic physical activity every week in combination with additional resistance training is beneficial for brain health. Furthermore, multidomain interventions such as diet, exercise, cognitive training, and vascular risk monitoring are effective in the prevention of cognitive decline. [8-18] However, a minimal intensity physical activity program did not improve any cognitive or composite measures of the participants compared with a health education program [18]; however, these findings should not disregard the overall beneficial effects of physical activity on well-being and cognitive function.
2 Consuming a regular healthy diet Healthy dietary regimens such as intake of fresh vegetables and fruits, consumption of long-term dewaxed brown rice, and consumption of Mediterranean diets are beneficial in the prevention and treatment of mental disorders; meanwhile, increased intake of saturated fatty acids could have negative impacts on age-related cognitive decline. Consumption of monounsaturated fatty acids and PUFA (specifically, n-3 PUFA) decreases the risk of cognitive deterioration, decline, and impairment and dementia. [19-26]
3 Smoking cessation Cigarette smoking is a major determinant for the development of dementia, regardless of age and gender. As a modifiable risk factor, smoking cessation and counseling would be effective in the prevention of dementia and other associated conditions. [27-32]
4 Air pollution prevention Higher and lower exposure to airborne pollutants, for example, particulate matter, nitrogen dioxide or nitrous oxides, and carbon monoxide, are all associated with increased risk of dementia. [33-38]
5 Reducing/eliminating alcohol consumption Alcohol use disorder is strongly associated with a higher risk of dementia; however, the dose-response relationship between alcohol consumption and cognitive impairment remains unclear. For example, light to moderate alcohol use in middle to late adulthood was associated with a reduced risk of cognitive impairment and dementia, but heavy alcohol use was associated with an increased risk of all types of dementia. In addition, consumption of >14 units of alcohol per week increases the risk of dementia, suggesting the proactive need for a downward revision of alcohol consumption guidelines globally to promote cognitive health. [39-45]
6 Exercising the mind and social activeness Engaging in stimulating activities, either intellectually, mentally or socially, for example, social association, interaction, intellectual stimulations, and moderate game-based interventions, could protect and prevent against dementia, and helps improve the condition. [46-54] However, caution must be ensured when playing video games and engaging in active gaming to prevent video game addiction. [55]
7 Good sleeping habits Articulated sleep and rest disruption or disturbance, habitual sleep duration of either short or long sleep periods, and sleep apnea are all risk factors and symptoms of various age-related neurodegenerative diseases such as dementia, Alzheimer’s disease, and Parkinson’s disease. Hence, treating sleep disorders would be beneficial in preventing and delaying the onset of dementia, and in improving the condition. [56-67]
8 Controlling health risks Hypertension, diabetes, and hearing loss (presbycusis) are higher risk factors of cognitive decline and various forms of dementia. [68-72] Hence, the prevention and treatments of medical conditions, such as diabetes, hypertension, obesity, and overweight, through regular medical checkups are warranted to mitigate the onset of certain types of dementia in the future.
9 Prevention of infection Helicobacter pylori infection, herpes simplex virus type 1 and cytomegalovirus infection, HIV infection, Toxoplasma gondii infection, fungi infection (cinerea and Cryptococcus curvatus, Alternaria, Botrytis, Candida, Cladosporium, and Malassezia), bacterial infection (treponema pallidum), and parasitic infestation (which causes neurocysticercosis) aggravate and cause the progression of dementia and other cognitive conditions. [73-80] Hence, prevention against various infections could be achieved by receiving vaccinations against specific infections; practicing personal, food, and environmental hygiene; and maintaining a healthy lifestyle (e.g., eating a balanced diet to fortify the immune system, performing regular exercise, and cessation of tobacco smoking and alcohol consumption).
10 Stress prevention An association was observed between stress (e.g., posttraumatic stress disorder and work-related stress) and the occurrence of mild cognitive impairment, dementia, and Alzheimer’s disease in the future. [81-84] In this regard, keeping a positive attitude; acceptance of situations or circumstances; being assertive instead of aggressive; meditation; engaging in yoga and tai-chi; exercising regularly, time management; setting limits; making time for hobbies, interests, and relaxation; getting adequate rest and sleep; not relying on alcohol and drugs or compulsive behaviors to reduce stress; receiving social support; and frequently seeking treatment from medical specialists are some of the effective measured to prevent and adequately manage stress.
11 Avoidance of injuries Moderate to severe TBI or any brain injury increases the risk of dementia, Alzheimer’s disease, Parkinson’s disease, and other cognitive conditions. [85,86] Hence, the frequent wearing of a seat belt; avoiding alcohol consumption and the use of drugs and prescription medicines that impair vision when driving; using a helmets’ frequent wearing of appropriate head protection during sporting activities; installation of handrails on both sides of the staircases and in bathrooms; putting a nonslip mat in the bathtub or shower; improving lighting in residential places; keeping the stairs and floors clear of clutter and slippery materials; performing regular exercise; and undergoing regular vision checkups are some of the measures to prevent TBI and other forms of injuries.
12 Preventing the impacts of social isolation and lockdown Loneliness is associated with an increased risk of dementia regardless of gender, race, ethnicity, education, and genetic factors. Perceived loneliness is a significant risk factor for all-cause dementia, and lack of social interaction with others are associated with risks of dementia. [87-89] In this regard, participating in game activities, reading books, watching television, listening to music, and engaging in physical activities are all beneficial in the prevention of loneliness. [90]
13 Prevention of depression Depression predisposes an individual to all-cause dementia. [91-97] Hence, ensuring ways to handle stress and improving self-esteem, taking good care of oneself, getting enough rest and sleep, eating a balanced diet, exercising regularly, reaching out to family members and friends during hard times, undergoing regular medical checkups, and visiting health specialists when bothered with health conditions or feeling depressed are some of the measures to prevent depression.
14 Continuing education Continuing education and maintaining a good cognitive ability decrease the risk of dementia. [98,99]

PUFA, polyunsaturated fatty acids; HIV, human immunodeficiency virus; TBI, traumatic brain injury.